Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase 2 study of idelalisib plus rituximab in treatment-naive older patients with chronic lymphocytic leukemia BLOOD O'Brien, S. M., Lamanna, N., Kipps, T. J., Flinn, I., Zelenetz, A. D., Burger, J. A., Keating, M., Mitra, S., Holes, L., Yu, A. S., Johnson, D. M., Miller, L. L., Kim, Y., Dansey, R. D., Dubowy, R. L., Coutre, S. E. 2015; 126 (25): 2686-2694
View details for DOI 10.1182/blood-2015-03-630947
View details for Web of Science ID 000368429600010